Radiologic Management of Gastric Varices Clinical Condition: Radiologic Management of Gastric Varices

[1]  S. Caldwell,et al.  Medical and endoscopic management of gastric varices. , 2011, Seminars in interventional radiology.

[2]  W. Saad,et al.  Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technical Results and Outcomes , 2011, Seminars in interventional radiology.

[3]  W. Saad,et al.  Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices. , 2011, Seminars in interventional radiology.

[4]  M. Davies,et al.  Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination. , 2010, Journal of vascular and interventional radiology : JVIR.

[5]  M. Sata,et al.  Long‐term results of balloon‐occluded retrograde transvenous obliteration for gastric fundal varices: Hepatic deterioration links to portosystemic shunt syndrome , 2010, Journal of gastroenterology and hepatology.

[6]  Sae-Jin Park,et al.  The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. , 2010, Journal of vascular and interventional radiology : JVIR.

[7]  J. Bosch,et al.  Management of varices and variceal hemorrhage in cirrhosis. , 2010, The New England journal of medicine.

[8]  N. Procaccini,et al.  Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. , 2009, Gastrointestinal endoscopy.

[9]  N. Kawai,et al.  Changes in Portal Systemic Pressure Gradient After Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices and Aggravation of Esophageal Varices , 2009, CardioVascular and Interventional Radiology.

[10]  Y. Cho,et al.  Treatment of patients with gastric variceal hemorrhage: Endoscopic N‐butyl‐2‐cyanoacrylate injection versus balloon‐occluded retrograde transvenous obliteration , 2009, Journal of gastroenterology and hepatology.

[11]  R. Balogun,et al.  Blood products, volume control, and renal support in the coagulopathy of liver disease. , 2009, Clinics in liver disease.

[12]  M. Hashizume,et al.  Long‐term results of balloon‐occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: A 10‐year experience , 2008, Journal of gastroenterology and hepatology.

[13]  D. Sinn,et al.  Effect of Balloon-Occluded Retrograde Transvenous Obliteration on the Natural History of Coexisting Esophageal Varices , 2008, Journal of clinical gastroenterology.

[14]  F. Chikamori,et al.  Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. , 2008, AJR. American journal of roentgenology.

[15]  M. Taniai,et al.  Long‐term follow up of esophageal varices after balloon‐occluded retrograde transvenous obliteration for gastric varices , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[16]  Sung W. Shin,et al.  Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. , 2007, AJR. American journal of roentgenology.

[17]  A. Sanyal,et al.  Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis , 2007, The American Journal of Gastroenterology.

[18]  T. Nishimura,et al.  Infusion of 50% glucose solution before injection of ethanolamine oleate during balloon-occluded retrograde transvenous obliteration. , 2007, Australasian radiology.

[19]  H. Rousseau,et al.  Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long‐term results of a randomized multicentre study , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[20]  H. Pan,et al.  A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. , 2007, Endoscopy.

[21]  J. Patrie,et al.  Enbucrilate for gastric varices: extended experience in 92 patients , 2007, Alimentary pharmacology & therapeutics.

[22]  M. Langer,et al.  The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): long-term follow-up of 100 patients , 2006, Acta radiologica.

[23]  M. Mori,et al.  Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. , 2006, World journal of gastroenterology.

[24]  Young Hwan Kim,et al.  [Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in patients with gastric variceal bleeding]. , 2006, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[25]  J. Limdi,et al.  The use of thrombin injections in the management of bleeding gastric varices: a single-center experience. , 2006, Gastrointestinal endoscopy.

[26]  F. Chang,et al.  A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N‐Butyl‐2‐Cyanoacrylate injection versus band ligation , 2006, Hepatology.

[27]  P. Hayes,et al.  Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents , 2006, European journal of gastroenterology & hepatology.

[28]  Y. Shiratori,et al.  Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  G. Passalacqua,et al.  TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. , 2005, AJR. American journal of roentgenology.

[30]  R. Yamada,et al.  Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. , 2005, AJR. American journal of roentgenology.

[31]  N. Patel,et al.  Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: current status. , 2005, Journal of vascular and interventional radiology : JVIR.

[32]  H. Takagi,et al.  Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts , 2005, Abdominal Imaging.

[33]  R. Edwards,et al.  Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. , 2004, Journal of vascular and interventional radiology : JVIR.

[34]  D. Gabriel,et al.  Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets , 2004, Journal of thrombosis and haemostasis : JTH.

[35]  F. Chikamori,et al.  Combination treatment of transjugular retrograde obliteration and endoscopic embolization for portosystemic encephalopathy with esophageal varices. , 2004, Hepato-gastroenterology.

[36]  R. Yamada,et al.  TIPS versus transcatheter sclerotherapy for gastric varices. , 2004, AJR. American journal of roentgenology.

[37]  O. Riggio,et al.  Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. , 2004, Radiology.

[38]  B. Ryan,et al.  A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. , 2004, Gastroenterology.

[39]  K. Binmoeller,et al.  A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans. , 2004, Gastrointestinal endoscopy.

[40]  R. Saxon.  A new era for transjugular intrahepatic portosystemic shunts? , 2004, Journal of vascular and interventional radiology : JVIR.

[41]  A. Berghold,et al.  Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. , 2004, Journal of vascular and interventional radiology : JVIR.

[42]  H. Rousseau,et al.  Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. , 2004, Gastroenterology.

[43]  M. Merli,et al.  Polytetrafluoroethylene-Covered Stent Grafts for TIPS Procedure: 1-Year Patency and Clinical Results , 2004, American Journal of Gastroenterology.

[44]  D. Kessel,et al.  Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding , 2003, American Journal of Gastroenterology.

[45]  Franz Hackl,et al.  Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE‐covered stentgrafts versus bare stents , 2003, Hepatology.

[46]  K. Binmoeller,et al.  N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis , 2003, American Journal of Gastroenterology.

[47]  M. Sata,et al.  Balloon‐occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension , 2003, Journal of gastroenterology and hepatology.

[48]  S. Matsumoto,et al.  Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[49]  S. Matsumoto,et al.  Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[50]  C. Yoon,et al.  Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Variceal Bleeding: Its Feasibility Compared with Transjugular Intrahepatic Portosystemic Shunt , 2003, Korean journal of radiology.

[51]  P. Hayes,et al.  Endoscopic use of human thrombin in bleeding gastric varices , 2002, American Journal of Gastroenterology.

[52]  M. Imamura,et al.  Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. , 2002, AJR. American journal of roentgenology.

[53]  J. Boadas,et al.  Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. , 2001, Gastroenterology.

[54]  Mei‐Hsiu Chen,et al.  A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices , 2001, Hepatology.

[55]  P. Pizcueta,et al.  Effects of blood volume restitution following a portal hypertensive–related bleeding in anesthetized cirrhotic rats , 2001, Hepatology.

[56]  F. Chikamori,et al.  Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. , 2001, Surgery.

[57]  T. Fukuda,et al.  Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. , 2001, Journal of vascular and interventional radiology : JVIR.

[58]  M. Hudson,et al.  Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment? , 2000, Liver.

[59]  L. Lindgren,et al.  Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study , 2000, The Lancet.

[60]  H. Rousseau,et al.  Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices , 1999, Hepatology.

[61]  M. Kono,et al.  Retrograde transvenous obliteration of gastric varices. , 1999, Radiology.

[62]  Roger M. Williams,et al.  Thrombin Is Effective in Arresting Bleeding from Gastric Variceal Hemorrhage , 1999, Digestive Diseases and Sciences.

[63]  I. Hirata,et al.  Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices , 1999, American Journal of Gastroenterology.

[64]  N. Kamata,et al.  [A clinical and portal hemodynamic analysis for obliteration of gastric-renal shunt communicated with gastric fundic varices]. , 1998, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[65]  A. Burroughs,et al.  "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. , 1998, Gastroenterology.

[66]  F. Vleggaar,et al.  Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population , 1998, European journal of gastroenterology & hepatology.

[67]  S. Sarin.  Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. , 1997, Gastrointestinal endoscopy.

[68]  P. Cole,et al.  The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. , 1997, Gastroenterology.

[69]  K. Koito,et al.  Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. , 1996, AJR. American journal of roentgenology.

[70]  K. Fukao,et al.  Transjugular retrograde obliteration for gastric varices , 1996, Abdominal Imaging.

[71]  S. Williams,et al.  Thrombin--an effective treatment for gastric variceal haemorrhage. , 1994, Gut.

[72]  S. Sarin,et al.  Prevalence, classification and natural history of gastric varices: A long‐term follow‐up study in 568 portal hypertension patients , 1992, Hepatology.

[73]  S. Sarin,et al.  Gastric varices: profile, classification, and management. , 1989, The American journal of gastroenterology.

[74]  J. Rodés,et al.  Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: Influence of the extent of portal‐systemic shunting , 1989, Hepatology.

[75]  N. Soehendra,et al.  N-Butyl-2-Cyanoacrylate: A Supplement to Endoscopic Sclerotherapy , 1987, Endoscopy.

[76]  T. Prindiville,et al.  Endoscopic injection sclerosis in bleeding gastric varices. , 1986, Gastrointestinal endoscopy.

[77]  新井 弘隆.  Emergency balloon-occluded retrograde transvenous obliteration for gastric varices , 2006 .

[78]  R. de Franchis.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. , 2005, Journal of hepatology.

[79]  Eun Soo Kim,et al.  [The clinical usefulness of balloon occluded retrograde transvenous obliteration in gastric variceal bleeding]. , 2003, Taehan Kan Hakhoe chi = The Korean journal of hepatology.

[80]  F. Chikamori,et al.  Transjugular retrograde obliteration for chronic portosystemic encephalopathy , 2000 .

[81]  H. Mori,et al.  [Balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices: therapeutic results and problems]. , 1999, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[82]  M. Kimura,et al.  Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices: A Feasibility Study , 1998, CardioVascular and Interventional Radiology.

[83]  S. D. Lee,et al.  Hepatic hemodynamic features in patients with esophageal or gastric varices. , 1993, Journal of hepatology.